Priya Shete, MD, MPH

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Avenue, #5J4
San Francisco CA 94110
PronounsShe/Her/Hers
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Yale University School of Medicine, New Haven, CTM.D.05/2007Medicine
    Johns Hopkins University, Baltimore, MDB.A.05/2001Biophysics
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training
    University of California, San Francisco06/2010Residency in Internal Medicine
    University of California, San Francisco06/2015Pulmonary and Critical Care Medicine Fellowship
    University of California, BerkeleyMPH12/2018Health Policy and Management
    University of California, San FranciscoCertificate01/2019Implementation Science

    Collapse Overview 
    Collapse Overview
    I am an Associate Professor of Medicine and Epidemiology based in the Division of Pulmonary and Critical Care Medicine at the University of California, San Francisco where my research has focused on improving access to and quality of tuberculosis (TB) care, and now COVID-19 care, for vulnerable populations. My research has highlighted the central importance of patient and health system barriers to quality of TB care in high burden settings. My portfolio leverages methods in implementation research, social epidemiology, modelling, and health economics that will allow us to better study and understand these barriers to care as well as to provide tools to support national TB programs and departments of public health with the design and implementation of interventions that curb these barriers. My research background is enhanced by my experience working with Global TB Programme of the World Health Organization. I have also served as a public health advisor for USAID with a focus on health system strengthening and with the California Department of Public Health and their team lead for modeling and analytics during the COVID-19 response. I also direct the UCSF Implementation Science Training Program. I serve as an attending physician on the Pulmonary Consult Service, in the Medical Intensive Care Unit, and in the Department of Public Health Tuberculosis Clinic at Zuckerberg San Francisco General Hospital.
    Collapse Global Health Equity

    Collapse Research 
    Collapse Research Activities and Funding
    Evaluating the Impact of Cash Transfers on Tuberculosis (TB) Care: ExaCT TB Study
    Swedish Research Council Jan 1, 2019 - Dec 31, 2022
    Role: Prinicipal Investigator
    Improving the Cascade of Care for Tuberculosis in Immigrant Populations in the United States
    NIH/NHLBI K12 A129905Jul 1, 2018 - Jun 20, 2021
    Role: Principal Investigator
    Support of Research Towards TB Elimination
    World Health Organization P0527037Oct 15, 2017 - Mar 30, 2018
    Role: Principal Investigator
    From Poverty to Cure: Overcoming Socioeconomic Barriers to Quality Tuberculosis Care
    Parker B Francis Foundation A129433Jul 1, 2017 - Jun 30, 2020
    Role: Principal Investigator
    SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: the SIMPLE TB study
    NIH/NHLBI R01HL130192Jan 15, 2016 - Dec 31, 2020
    Role: Co-investigator
    Economic Analysis for Prevention of Disease (EMPoD)
    Centers for Disease Control and Prevention (CDC) U38PS004649Sep 30, 2014 - Sep 29, 2019
    Role: Co-investigator/TB Lead

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fostering public health and academic partnerships during and beyond a public health emergency: lessons learned from COVID-19. Am J Epidemiol. 2025 Jan 16. León TM, White LA, Spindler H, Schwab J, Petersen ML, Vargo J, Wheeler W, Shete PB, Jain S, Watt J, Pan ES, Kilpatrick AM. PMID: 39825492.
      View in: PubMed   Mentions:    Fields:    
    2. Impact of a multicomponent strategy including decentralized molecular testing for tuberculosis on mortality: planned analysis of a cluster-randomized trial in Uganda. EClinicalMedicine. 2024 Dec; 78:102953. Katamba A, Mochizuki T, Nalugwa T, Nantale M, Oyuku D, Nabwire S, Babirye D, Musinguzi J, Nakawesa A, Nekesa I, Turyahabwe S, Joloba M, Dowdy DW, Moore DAJ, Davis JL, Shete P, Adams K, Reza T, Fielding K, Cattamanchi A. PMID: 39659443; PMCID: PMC11629260.
      View in: PubMed   Mentions:
    3. “Think. Test. Treat TB” in Action: An Innovative Primary Care and Public Health Partnership to Improve Tuberculosis Prevention and Care. NEJM Catalyst. 2024 Jul 17; 5(8). Tang TA, Dong DZ, Lee LM, Murrill MM, Shete SP, Graves GS. .
      View in: Publisher Site   Mentions:
    4. California's COVID-19 Vaccine Equity Policy: Cases, Hospitalizations, And Deaths Averted In Affected Communities. Health Aff (Millwood). 2024 05; 43(5):632-640. Hoover CM, Estus E, Kwan A, Raymond K, Sreedharan T, León T, Jain S, Shete PB. PMID: 38709962.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    5. Feasibility of a social protection linkage program for individuals at-risk for tuberculosis in Uganda. PLOS Glob Public Health. 2023; 3(12):e0002122. Nanyunja G, Kadota JL, Namale C, Hudson M, Nalugwa T, Turyahabwe S, Cattamanchi A, Katamba A, Muhumuza P, Shete PB. PMID: 38064449; PMCID: PMC10707648.
      View in: PubMed   Mentions: 1  
    6. The socioeconomic burden of pediatric tuberculosis and role of child-sensitive social protection. BMC Public Health. 2023 11 25; 23(1):2339. Shah K, Nakafeero J, Kadota JL, Wambi P, Nanyonga G, Kiconco E, Deus A, Sekadde MP, Nabukenya-Mudiope MG, Tukamuhebwa HA, Mupere E, Mohanty S, Cattamanchi A, Wobudeya E, Shete PB, Jaganath D. PMID: 38007477; PMCID: PMC10675962.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Evaluating the impact of cash transfers on tuberculosis (ExaCT TB): a stepped wedge cluster randomised controlled trial. ERJ Open Res. 2023 May; 9(3). Shete PB, Kadota JL, Nanyunja G, Namale C, Nalugwa T, Oyuku D, Turyahabwe S, Kiwanuka N, Cattamanchi A, Katamba A. PMID: 37342088; PMCID: PMC10277874.
      View in: PubMed   Mentions: 1  
    8. Screening for Latent Tuberculosis Infection Among Non-US-Born Adults in the US: A Path Toward Elimination. JAMA. 2023 05 02; 329(17):1457-1459. Shete PB, Tang AS, Flood J. PMID: 37129665.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    9. The impact of social protection interventions on treatment and socioeconomic outcomes of people with tuberculosis and their households: Protocol for a systematic review and meta-analysis. Wellcome Open Res. 2023; 8:175. Hudson M, Todd H, Nalugwa T, Boccia D, Wingfield T, Shete PB. PMID: 37744729; PMCID: PMC10511851.
      View in: PubMed   Mentions:
    10. Evaluating Social Protection Policies With an Implementation Science Framework: India's Direct Benefit Transfer for Tuberculosis Comment on "Does Direct Benefit Transfer Improve Outcomes Among People With Tuberculosis? - A Mixed-Methods Study on the Need for a Review of the Cash Transfer Policy in India". Int J Health Policy Manag. 2023; 12:7698. Schraufnagel AM, Shete PB. PMID: 37579424; PMCID: PMC10461881.
      View in: PubMed   Mentions: 2     Fields:    
    11. Social Protection Interventions for TB-Affected Households: A Scoping Review. Am J Trop Med Hyg. 2023 04 05; 108(4):650-659. Todd H, Hudson M, Grolmusova N, Kazibwe J, Pearman J, Skender K, Tran PB, Boccia D, Shete PB, Wingfield T. PMID: 36806490; PMCID: PMC10076998.
      View in: PubMed   Mentions: 5     Fields:    
    12. A Matter of Inclusion: A Cluster-Randomized Trial to Access the Effect of Food Vouchers Versus Traditional Treatment on Tuberculosis Outcomes in Brazil. Am J Trop Med Hyg. 2022 12 14; 107(6):1281-1287. Reis-Santos B, Locatelli R, Oliosi J, Sales CM, do Prado TN, Shete PB, Riley LW, Maciel EL. PMID: 36375455; PMCID: PMC9768270.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. COVID-19 Testing Strategies for K-12 Schools in California: A Cost-Effectiveness Analysis. Int J Environ Res Public Health. 2022 07 30; 19(15). Maya S, McCorvie R, Jacobson K, Shete PB, Bardach N, Kahn JG. PMID: 35954728; PMCID: PMC9367893.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    14. Risk factor targeting for vaccine prioritization during the COVID-19 pandemic. Sci Rep. 2022 Feb 23; 12(1):3055. Chapman LAC, Shukla P, Rodríguez-Barraquer I, Shete PB, León TM, Bibbins-Domingo K, Rutherford GW, Schechter R, Lo NC. PMID: 35197495; PMCID: PMC8866501.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    15. Readiness to implement on-site molecular testing for tuberculosis in community health centers in Uganda. Implement Sci Commun. 2022 Feb 02; 3(1):9. Nalugwa T, Handley M, Shete P, Ojok C, Nantale M, Reza T, Katamba A, Cattamanchi A, Ackerman S. PMID: 35109936; PMCID: PMC8812219.
      View in: PubMed   Mentions: 5  
    16. The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease. Epidemiology. 2022 01 01; 33(1):75-83. Menzies NA, Shrestha S, Parriott A, Marks SM, Hill AN, Dowdy DW, Shete PB, Cohen T, Salomon JA. PMID: 34669631; PMCID: PMC8633045.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis. N Engl J Med. 2021 12 23; 385(26):2441-2450. Cattamanchi A, Reza TF, Nalugwa T, Adams K, Nantale M, Oyuku D, Nabwire S, Babirye D, Turyahabwe S, Tucker A, Sohn H, Ferguson O, Thompson R, Shete PB, Handley MA, Ackerman S, Joloba M, Moore DAJ, Davis JL, Dowdy DW, Fielding K, Katamba A. PMID: 34936740; PMCID: PMC9212879.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    18. Nonpharmaceutical Interventions Remain Essential to Reducing Coronavirus Disease 2019 Burden Even in a Well-Vaccinated Society: A Modeling Study. Open Forum Infect Dis. 2021 Sep; 8(9):ofab415. León TM, Vargo J, Pan ES, Jain S, Shete PB. PMID: 34514021; PMCID: PMC8419741.
      View in: PubMed   Mentions: 5  
    19. Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021 08 01; 204(3):e26-e50. Thakur N, Lovinsky-Desir S, Appell D, Bime C, Castro L, Celedón JC, Ferreira J, George M, Mageto Y, Mainous III AG, Pakhale S, Riekert KA, Roman J, Ruvalcaba E, Sharma S, Shete P, Wisnivesky JP, Holguin F. PMID: 34347574; PMCID: PMC8513588.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    20. Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda. PLoS One. 2021; 16(7):e0253927. Samuels THA, Shete PB, Ojok C, Nalugwa T, Farr K, Turyahabwe S, Katamba A, Cattamanchi A, Moore DAJ. PMID: 34270582; PMCID: PMC8284677.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California. Health Aff (Millwood). 2021 06; 40(6):870-878. Reitsma MB, Claypool AL, Vargo J, Shete PB, McCorvie R, Wheeler WH, Rocha DA, Myers JF, Murray EL, Bregman B, Dominguez DM, Nguyen AD, Porse C, Fritz CL, Jain S, Watt JP, Salomon JA, Goldhaber-Fiebert JD. PMID: 33979192; PMCID: PMC8458028.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    22. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity. PLoS One. 2021; 16(4):e0249012. Mirzazadeh A, Kahn JG, Haddad MB, Hill AN, Marks SM, Readhead A, Barry PM, Flood J, Mermin JH, Shete PB. PMID: 33793612; PMCID: PMC8016318.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    23. Patient Perspectives and Willingness to Accept Incentives for Tuberculosis Diagnostic Evaluation in Uganda. Value Health Reg Issues. 2021 Sep; 25:48-56. Kadota JL, Nabwire S, Nalugwa T, White JS, Cattamanchi A, Katamba A, Shete PB. PMID: 33773327; PMCID: PMC8434939.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Costs along the TB diagnostic pathway in Uganda. Int J Tuberc Lung Dis. 2021 01 01; 25(1):61-63. Tucker A, Oyuku D, Nalugwa T, Nantale M, Ferguson O, Farr K, Reza TF, Shete PB, Cattamanchi A, Dowdy DW, Sohn H, Katamba A. PMID: 33384046; PMCID: PMC7927348.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States. Ann Am Thorac Soc. 2020 12; 17(12):1639-1642. Shrestha S, Parriott A, Menzies NA, Shete PB, Hill AN, Marks SM, Dowdy DW. PMID: 32916062; PMCID: PMC7923126.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic. Int J Tuberc Lung Dis. 2020 11 01; 24(11):1212-1214. Kadota JL, Reza TF, Nalugwa T, Kityamuwesi A, Nanyunja G, Kiwanuka N, Shete P, Davis JL, Dowdy D, Turyahabwe S, Katamba A, Cattamanchi A. PMID: 33172531; PMCID: PMC7895296.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsPHPublic Health
    27. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India. Infect Dis Poverty. 2020 Oct 19; 9(1):144. Rupani MP, Cattamanchi A, Shete PB, Vollmer WM, Basu S, Dave JD. PMID: 33076969; PMCID: PMC7574230.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    28. Use of Chest Imaging in the Diagnosis and Management of COVID-19: A WHO Rapid Advice Guide. Radiology. 2021 02; 298(2):E63-E69. Akl EA, Blažic I, Yaacoub S, Frija G, Chou R, Appiah JA, Fatehi M, Flor N, Hitti E, Jafri H, Jin ZY, Kauczor HU, Kawooya M, Kazerooni EA, Ko JP, Mahfouz R, Muglia V, Nyabanda R, Sanchez M, Shete PB, Ulla M, Zheng C, van Deventer E, Perez MDR. PMID: 32729811; PMCID: PMC7393953.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCells
    29. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination. Public Health Rep. 2020 Jul/Aug; 135(1_suppl):38S-43S. Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shrestha S, Flood J, Hill AN. PMID: 32735183; PMCID: PMC7407050.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    30. Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping review. BMJ Glob Health. 2020 07; 5(7). Chimoyi LA, Lienhardt C, Moodley N, Shete P, Churchyard GJ, Charalambous S. PMID: 32636313; PMCID: PMC7342464.
      View in: PubMed   Mentions: 5     Fields:    
    31. Modeling the Impact of Recommendations for Primary Care-Based Screening for Latent Tuberculosis Infection in California. Public Health Rep. 2020 Jul/Aug; 135(1_suppl):172S-181S. Parriott A, Kahn JG, Ashki H, Readhead A, Barry PM, Goodell AJ, Flood J, Shete PB. PMID: 32735191; PMCID: PMC7407051.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    32. Management and Outcomes of Critically-III Patients with COVID-19 Pneumonia at a Safety-net Hospital in San Francisco, a Region with Early Public Health Interventions: A Case Series. medRxiv. 2020 May 29. Vanderburg S, Alipanah N, Crowder R, Yoon C, Wang R, Thakur N, Slown K, Shete PB, Rofael M, Metcalfe JZ, Merrifield C, Marquez C, Malcolm K, Lipnick M, Jain V, Gomez A, Burns G, Brown LB, Berger C, Auyeung V, Cattamanchi A, Hendrickson CM. PMID: 32511538; PMCID: PMC7273306.
      View in: PubMed   Mentions:
    33. Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB). Implement Sci. 2020 04 21; 15(1):24. Reza TF, Nalugwa T, Farr K, Nantale M, Oyuku D, Nakaweesa A, Musinguzi J, Vangala M, Shete PB, Tucker A, Ferguson O, Fielding K, Sohn H, Dowdy D, Moore DAJ, Davis JL, Ackerman SL, Handley MA, Katamba A, Cattamanchi A. PMID: 32316993; PMCID: PMC7171793.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    34. The University of California San Francisco (UCSF) Training Program in Implementation Science: Program Experiences and Outcomes. Front Public Health. 2020; 8:94. Shete PB, Gonzales R, Ackerman S, Cattamanchi A, Handley MA. PMID: 32292773; PMCID: PMC7118197.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    35. Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective. BMC Health Serv Res. 2020 Mar 04; 20(1):162. Nalugwa T, Shete PB, Nantale M, Farr K, Ojok C, Ochom E, Mugabe F, Joloba M, Dowdy DW, Moore DAJ, Davis JL, Cattamanchi A, Katamba A. PMID: 32131814; PMCID: PMC7057496.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    36. Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California. Am J Respir Crit Care Med. 2020 02 01; 201(3):356-365. Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay GR, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. PMID: 31626560; PMCID: PMC7464931.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    37. Implementation science to improve the quality of tuberculosis diagnostic services in Uganda. J Clin Tuberc Other Mycobact Dis. 2020 Feb; 18:100136. Cattamanchi A, Berger CA, Shete PB, Turyahabwe S, Joloba M, Moore DA, Davis LJ, Katamba A. PMID: 31879703; PMCID: PMC6920311.
      View in: PubMed   Mentions: 13  
    38. Economic analyses to inform public health decision-making for tuberculosis: the role of understanding implementation. BMC Med. 2019 11 29; 17(1):224. Shete PB, Kahn JG. PMID: 31783754; PMCID: PMC6883591.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    39. Feasibility of a short message service (SMS) intervention to deliver tuberculosis testing results in peri-urban and rural Uganda. J Clin Tuberc Other Mycobact Dis. 2019 Aug; 16:100110. Babirye D, Shete PB, Farr K, Nalugwa T, Ojok C, Nantale M, Oyuku D, Ayakaka I, Katamba A, Davis JL, Nadunga D, Joloba M, Moore D, Cattamanchi A. PMID: 31720434; PMCID: PMC6830162.
      View in: PubMed   Mentions: 11  
    40. Introducing risk inequality metrics in tuberculosis policy development. Nat Commun. 2019 06 06; 10(1):2480. Gomes MGM, Oliveira JF, Bertolde A, Ayabina D, Nguyen TA, Maciel EL, Duarte R, Nguyen BH, Shete PB, Lienhardt C. PMID: 31171791; PMCID: PMC6554307.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    41. Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. Diagnostics (Basel). 2019 May 30; 9(2). Alipanah N, Shete PB, Nguyen H, Nguyen NV, Luu L, Pham T, Nguyen H, Nguyen P, Tran MC, Pham N, Phan H, Phillips PPJ, Cattamanchi A, Nahid P. PMID: 31151255; PMCID: PMC6627302.
      View in: PubMed   Mentions: 2  
    42. Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up. J Clin Tuberc Other Mycobact Dis. 2019 May; 15:100099. Farr K, Nalugwa T, Ojok C, Nantale M, Nabwire S, Oyuku D, Shete PB, Han AH, Fielding K, Joloba M, Mugabe F, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A. PMID: 31720425; PMCID: PMC6830152.
      View in: PubMed   Mentions: 6  
    43. Outlook for tuberculosis elimination in California: An individual-based stochastic model. PLoS One. 2019; 14(4):e0214532. Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG. PMID: 30964878; PMCID: PMC6456190.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    44. Building a tuberculosis-free world: The Lancet Commission on tuberculosis. Lancet. 2019 Mar 30; 393(10178):1331-1384. Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP. PMID: 30904263.
      View in: PubMed   Mentions: 157     Fields:    Translation:HumansCellsPHPublic Health
    45. Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2019 Mar 19; 19(1):268. Shete PB, Farr K, Strnad L, Gray CM, Cattamanchi A. PMID: 30890135; PMCID: PMC6425614.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    46. Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates. PLoS One. 2019; 14(2):e0212617. Reis-Santos B, Shete P, Bertolde A, Sales CM, Sanchez MN, Arakaki-Sanchez D, Andrade KB, Gomes MGM, Boccia D, Lienhardt C, Maciel EL. PMID: 30794615; PMCID: PMC6386534.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    47. Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort study. Lancet Glob Health. 2019 02; 7(2):e219-e226. Oliosi JGN, Reis-Santos B, Locatelli RL, Sales CMM, da Silva Filho WG, da Silva KC, Sanchez MN, de Andrade KVF, de Araújo GS, Shete PB, Pereira SM, Riley LW, Lienhardt C, Maciel ELN. PMID: 30584050.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    48. Message to world leaders: we cannot end tuberculosis without addressing the social and economic burden of the disease. Lancet Glob Health. 2018 12; 6(12):e1272-e1273. Shete PB, Reid M, Goosby E. PMID: 30224288.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    49. Defining a migrant-inclusive tuberculosis research agenda to end TB. Int J Tuberc Lung Dis. 2018 08 01; 22(8):835-843. Shete PB, Boccia D, Dhavan P, Gebreselassie N, Lönnroth K, Marks S, Matteelli A, Posey DL, van der Werf MJ, Winston CA, Lienhardt C. PMID: 29991390; PMCID: PMC6407119.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    50. Modelling the impact of social protection on tuberculosis: the S-PROTECT project. BMC Public Health. 2018 06 26; 18(1):786. Boccia D, Rudgard W, Shrestha S, Lönnroth K, Eckhoff P, Golub J, Sanchez M, Maciel E, Rasella D, Shete P, Pedrazzoli D, Houben R, Chang S, Dowdy D. PMID: 29940906; PMCID: PMC6020219.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    51. Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda. Int J Tuberc Lung Dis. 2018 05 01; 22(5):530-536. Ggita JM, Ojok C, Meyer AJ, Farr K, Shete PB, Ochom E, Turimumahoro P, Babirye D, Mark D, Dowdy D, Ackerman S, Armstrong-Hough M, Nalugwa T, Ayakaka I, Moore D, Haberer JE, Cattamanchi A, Katamba A, Davis JL. PMID: 29663958; PMCID: PMC6350252.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    52. Measuring success: The challenge of social protection in helping eliminate tuberculosis. PLoS Med. 2017 11; 14(11):e1002419. Shete PB, Dowdy DW. PMID: 29112688; PMCID: PMC5675305.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    53. Harnessing the Power of Data to Guide Local Action and End Tuberculosis. J Infect Dis. 2017 11 06; 216(suppl_7):S669-S672. Sismanidis C, Shete PB, Lienhardt C, Floyd K, Raviglione M. PMID: 29117345; PMCID: PMC5853537.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    54. Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda. PLoS One. 2017; 12(8):e0180122. Shete PB, Ravindran R, Chang E, Worodria W, Chaisson LH, Andama A, Davis JL, Luciw PA, Huang L, Khan IH, Cattamanchi A. PMID: 28767658; PMCID: PMC5540581.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    55. Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy. Int J Tuberc Lung Dis. 2017 07 01; 21(7):746-752. Shete PB, Nalugwa T, Farr K, Ojok C, Nantale M, Howlett P, Haguma P, Ochom E, Mugabe F, Joloba M, Chaisson LH, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A. PMID: 28633698; PMCID: PMC5479151.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    56. Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda. Int J Tuberc Lung Dis. 2015 Aug; 19(8):912-7. Shete PB, Haguma P, Miller CR, Ochom E, Ayakaka I, Davis JL, Dowdy DW, Hopewell P, Katamba A, Cattamanchi A. PMID: 26162356; PMCID: PMC6602531.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    57. Quality of tuberculosis care in India: a systematic review. Int J Tuberc Lung Dis. 2015 Jul; 19(7):751-63. Satyanarayana S, Subbaraman R, Shete P, Gore G, Das J, Cattamanchi A, Mayer K, Menzies D, Harries AD, Hopewell P, Pai M. PMID: 26056098; PMCID: PMC4462173.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    58. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management. Int J Drug Policy. 2007 Oct; 18(5):426-32. Lazarus JV, Shete PB, Eramova I, Merkinaite S, Matic S. PMID: 17854732.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    59. A unique subpopulation of Tbr1-expressing deep layer neurons in the developing cerebral cortex. Mol Cell Neurosci. 2006 May-Jun; 32(1-2):200-14. Kolk SM, Whitman MC, Yun ME, Shete P, Donoghue MJ. PMID: 16858776.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    60. Erratum to “A unique subpopulation of Tbr1-expressing deep layer neurons in the developing cerebral cortex” [Mol. Cell. Neurosci. 30 (2005) 538–551]. Molecular and Cellular Neuroscience. 2006 May 1; 32(1-2):199. Kolk KS, Whitman WM, Yun YM, Shete SP, Donoghue DM. .
      View in: Publisher Site   Mentions:
    61. A unique subpopulation of Tbr1-expressing deep layer neurons in the developing cerebral cortex. Mol Cell Neurosci. 2005 Dec; 30(4):538-51. Kolk SM, Whitman MC, Yun ME, Shete P, Donoghue MJ. PMID: 16188453.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    62. Physician knowledge of catch-up regimens and contraindications for childhood immunizations. Pediatrics. 2003 May; 111(5 Pt 1):925-32. Cohen NJ, Lauderdale DS, Shete PB, Seal JB, Daum RS. PMID: 12728067.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsPHPublic Health
    63. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sex Transm Dis. 2002 Nov; 29(11):655-64. Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA. PMID: 12438901.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    64. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. J Infect Dis. 2002 Sep 01; 186(5):661-7. Hussain FM, Boyle-Vavra S, Shete PB, Daum RS. PMID: 12195353.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    65. Real versus theoretical: assessing the risks and benefits of postponing the hepatitis B vaccine birth dose. Pediatrics. 2002 Apr; 109(4):701-3. Shete PB, Daum RS. PMID: 11927717.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Priya's Networks
    Concepts (226)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (49)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.